How much funding has Recens Medical raised?

Recens Medical has raised $34.3M in total funding, most recently a Series B round.

Who are Recens Medical's investors?

Recens Medical's investors include LB Investment, KB Securities, STIC Ventures.

When was Recens Medical founded?

Recens Medical was founded in 2016.

Where is Recens Medical headquartered?

Recens Medical is headquartered in Ulsan, South Korea.

What industry is Recens Medical in?

Recens Medical operates in Healthcare.

How many employees does Recens Medical have?

Recens Medical has 11-50 employees.

Recens Medical

Ulsan, South Korea · Founded 2016 · $34.3M raised

Healthcare

Headquarters: Ulsan
Employees: 11–50
Founded: 2016
Business Model: B2B

Website: recensmedical.co.kr
Total Funding: $34.3M
Last Round: $6.0M Series BJan 2024
Rounds: 2

About

RecensMedical is a South Korean medical device company founded in 2016 by Professor Gun-Ho Kim at UNIST (Ulsan National Institute of Science and Technology), developing next-generation precision cooling technology for medical applications in ophthalmology, dermatology, and veterinary care. Its flagship product OcuCool received FDA De Novo approval in 2024 as the first cooling anesthesia device cleared by the FDA, enabling rapid non-pharmaceutical topical anesthesia for ophthalmic procedures such as intravitreal injections. The company's TargetCool system addresses painless laser and needle therapies in dermatology, while VetEase serves the veterinary market. RecensMedical listed on the Korean KOSDAQ exchange in 2026 and holds GMP-certified manufacturing facilities at UNIST in Ulsan, South Korea.

Summary

Recens Medical is a Healthcare company based in Ulsan, South Korea, founded in 2016. It has raised $34.3M in total across 2 rounds, most recently a $6.0M Series B round in Jan 2024. Investors include LB Investment, KB Securities and STIC Ventures.